Lipkin's Monster ME/CFS Study: Microbes, Immunity & Big Data
The Microbe Discovery Project outlines an ambitious new study by top researchers that has collected patient samples, but needs desperately funds to complete the work.
Discuss the article on the Forums.

Rituximab for Hep C not responding to antivirals - relapse risk remains

Discussion in 'Other Health News and Research' started by natasa778, Jan 31, 2014.

  1. natasa778

    natasa778 Senior Member

    Messages:
    1,716
    Likes:
    2,086
    Small scale trial but very encouraging and interesting results

    A randomized controlled trial of rituximab following failure of antiviral therapy for hepatitis C virus-associated cryoglobulinemic vasculitis.


     
    Bob likes this.
  2. natasa778

    natasa778 Senior Member

    Messages:
    1,716
    Likes:
    2,086
    Should have mentioned FATIGUE being present in 2/3 of Hep C patients, amongst other clinical presentations. Would be interesting to know if that changes after Rituximab treatment ...

    Cryoglobulin production present in over a third.
     

See more popular forum discussions.

Share This Page